I know HC frowns upon cross referencing other stocks, but I feel this is relevant.
A small bio tech called Living Cell Technologies (ASX: LCT) is awaiting results from a small sample testing for a treatment for Parkinson’s. They may get approval for paying patients in New Zealand next year.
Here comes the relevant part. If this helps with proof of concept in such a “Hot Button” affliction as PD, the regulators will struggle to fight the tide of opinion for approval.
LCT Sp is on a tear, so some people think it will fly.
Floodgates open for MSB if that happens.
DYOR
2 Major Changes, page-2
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 71720 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 10463 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |